Showing results (291-300 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|August 21, 2013
A review of statistical issues with progression-free survival as an interval-censored time-to-event endpointXing Sun, Xiaoyun Li, Cong Chen, et al.Journal of Biopharmaceutical Statistics|August 21, 2013
Bayesian inference for skew-normal mixture models with left-censoringGetachew A DagneJournal of Biopharmaceutical Statistics|June 22, 2013
Optimal allocation of sample sizes to multicenter clinical trialsDejian Lai, Kuang-Chao Chang, Mohammad H Rahbar, et al.Journal of Biopharmaceutical Statistics|June 22, 2013
On the distribution of batch shelf livesMichelle Quinlan, Walter Stroup, David Christopher, et al.Journal of Biopharmaceutical Statistics|June 22, 2013
Five interval estimators of the risk difference under stratified randomized clinical trials with noncompliance and repeated measurementsKung-Jong Lui, Kuang-Chao ChangJournal of Biopharmaceutical Statistics|October 22, 2013
Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputationJames R Carpenter, James H Roger, Michael G KenwardJournal of Biopharmaceutical Statistics|October 22, 2013
A multilevel model for hierarchical, repeated, and overdispersed time-to-event outcomes and its estimation strategiesAchmad Efendi, Geert MolenberghsJournal of Biopharmaceutical Statistics|September 1, 1993
Sample size determination using an interim analysisD R BristolJournal of Biopharmaceutical Statistics|September 1, 1993
A log-normal model for individual bioequivalenceK F PhillipsJournal of Biopharmaceutical Statistics|September 1, 1993
Structure-activity maps for visualizing the graph variables arising in drug designM JohnsonPageof 216